Senzime AB (publ) (STO:SEZI)
Market Cap | 858.39M |
Revenue (ttm) | 69.86M |
Net Income (ttm) | -125.46M |
Shares Out | 157.22M |
EPS (ttm) | -1.01 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 60,610 |
Average Volume | 336,471 |
Open | 5.50 |
Previous Close | 5.46 |
Day's Range | 5.40 - 5.50 |
52-Week Range | 3.60 - 9.60 |
Beta | 0.67 |
RSI | 57.60 |
Earnings Date | Jul 18, 2025 |
About Senzime AB
Senzime AB (publ), a medical device company, develops, manufactures, and markets algorithm-powered patient monitoring systems to increase patient safety during and after surgery in Europe and the United States. It provides TetraGraph, a quantitative neuromuscular transmission monitor, which supports neuromuscular blockade management from induction to recovery; and ExSpiron, a non-invasive monitoring system that uses bioelectrical impedance sensor to measure the tissue’s opposition to carrying an alternating electrical current. The company has a... [Read more]
Financial Performance
In 2024, Senzime AB's revenue was 58.48 million, an increase of 63.55% compared to the previous year's 35.75 million. Losses were -118.73 million, -11.50% less than in 2023.
Financial StatementsNews

Invitation to Presentation of Senzime's Second Quarter 2025 Report
UPPSALA, SE / ACCESS Newswire / July 8, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) invites investors, analysts, and media to a webcast presentation of the second quarter report for 20...

Senzime Secures Major U.S. Hospital Contract for Supply and Scientific Collaboration
UPPSALA, SWEDEN / ACCESS Newswire / July 1, 2025 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced it has secured a contract to supply TetraGraph monitors and enter a scientific collaboration with ...

Senzime Granted New U.S. Patent for TetraGraph System
UPPSALA, SWEDEN / ACCESS Newswire / July 1, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF), today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent protecting and br...

BULLETIN from EXTRAORDINARY GENERAL MEETING in Senzime AB (publ)
UPPSALA, SWEDEN / ACCESS Newswire / June 30, 2025 / The extraordinary general meeting in Senzime AB (STO:SEZI)(OTCQX:SNZZF), corp. reg. no 556565-5734 (the "Company") was held on 30 June 2025, whereby...

New Number of Shares and Votes in Senzime AB (publ)
UPPSALA, SE / ACCESS Newswire / June 30, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The number of shares and votes in Senzime AB (publ) ("Senzime") has increased during June due to the directed share is...

NOTICE OF extraordinary GENERAL MEETING in Senzime AB (PUBL)
UPPSALA, SE / ACCESS Newswire / June 2, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby to an extraordinary general ...

Senzime Applauds Announcement of Upcoming European Pediatric Guidelines of Neuromuscular Monitoring
UPPSALA, SE / ACCESS Newswire / May 26, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Lisbon, Portugal - Senzime AB (publ.) welcomes today's pre-announcement of the first pediatric guidelines of quantitati...

BULLETIN from Annual General Meeting in Senzime AB (publ)
UPPSALA, SE / ACCESS Newswire / May 19, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The annual general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the "Company") was held on 19 May 2025 at t...

Senzime Launches Medical Affairs Division and Education Platform to Drive Transformation in Anesthesia Monitoring
UPPSALA, Sweden and ST. LOUIS , May 13, 2025 /PRNewswire/ -- Senzime, a global leader in precision-based perioperative monitoring solutions, today announced the formation of a new Medical Affairs divi...

Senzime Secures New TetraGraph Contract with State-Wide University Hospital System in Southern US
UPPSALA, SE / ACCESS Newswire / April 29, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime AB today announced that it has secured another major US contract, this time with a top-rank...

Senzime Publishes Annual and Sustainability Report for 2024
UPPSALA, SWEDEN / ACCESS Newswire / April 24, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) announces today that the company's annual and sustainability report for 2024 is published and available at the webs...

Senzime Secures New System-Wide Contract with Major Pacific Northwest US Healthcare System
UPPSALA, SE / ACCESS Newswire / April 23, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured an additional system-wide contract with a US healthcare system. The contract includ...

Interim Report January-March 2025: 94 Percent Growth
UPPSALA, SE / ACCESS Newswire / April 22, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2025 is now available on the company's website www.senzime.com...

Invitation to Presentation of Senzime's First Quarter 2025 Report
UPPSALA, SWEDEN / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation of the first quarter report for 2025 on April 22, ...

NOTICE OF ANNUAL GENERAL MEETING in Senzime AB (publ)
UPPSALA, SE / ACCESS Newswire / April 14, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual gene...

Senzime Comments on US Market Tariffs
UPPSALA, SE / ACCESS Newswire / April 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Uppsala, Sweden - Senzime comments on the April 2 announcement on imposed new US import tariffs effective April 9, 202...

New Number of Shares and Votes in Senzime AB (publ)
UPPSALA, SE / ACCESS Newswire / April 1, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - The number of shares and votes in Senzime has increased during the month of March due to the directed issue of shares ...

Senzime Secures Additional US Hospital System Contracts
UPPSALA, SE / ACCESS Newswire / March 14, 2025 / Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured new important US hospital system contracts including initial delivery of 60 next...
Senzime AB (SNZZF) Q4 2024 Earnings Call Highlights: Strong Growth Amidst Strategic Shifts
Senzime AB (SNZZF) Q4 2024 Earnings Call Highlights: Strong Growth Amidst Strategic Shifts

Interim report January - December 2024: Our Rapid Growth Journey Continued in 2024 with a 65% Growth Rate
UPPSALA, SWEDEN / ACCESS Newswire / February 17, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB's (publ) interim report for January - December 2024 is now available on the company's website www.sen...

Invitation to Presentation of Senzime's Fourth Quarter 2024 Report
UPPSALA, SE / ACCESS Newswire / February 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the fourth quarter report for 2024 on Fe...

Senzime Reaches Second Milestone of Masimo Collaboration with Launch of Integration to Iris Gateway
UPPSALA, SWEDEN / ACCESSWIRE / January 13, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime AB (publ.), a leader in precision-based patient monitoring, today announced that the company has reached a sec...

Senzime Secures Multiple New Hospital Contracts for its Next-Generation TetraGraph System
UPPSALA, SE / ACCESSWIRE / January 7, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime,an industry leader in precision-based patient monitoring solutions, today announced multiple hospital contract wins...

New Number of Shares and Votes in Senzime AB (publ)
UPPSALA, SWEDEN / ACCESSWIRE / January 3, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) The number of shares and votes in Senzime AB (publ) ("Senzime") has increased during December due to the directed share...
Senzime AB (SNZZF) Q3 2024 Earnings Call Highlights: Record Sales Growth and Strategic Market ...
Senzime AB (SNZZF) Q3 2024 Earnings Call Highlights: Record Sales Growth and Strategic Market Expansion